🎙 The Evolving Heart Health Landscape Part 2 Ep. 263

MedEvidence! Truth Behind the Data

Send us a text

In this second and final part of this series, Dr. Michael Koren and Dr. Seth Baum discuss the importance of patient retention in cardiovascular clinical trials. They highlight how participants in these trials, even those on placebos, often experience better health outcomes due to increased medical attention. They stress the need for clear communication at the outset, proper participant selection, and continued engagement through education and personal interactions. Dropping out of a trial can negatively impact the study’s validity and broader medical advancements.
Dr. Koren's Key takeaways

• Patient retention is critical for good clinical trial data
• Many patients experience medical benefits even when taking a placebo
• Beyond personal benefits, clinical trials can help millions or billions of people

Recorded 11/11/2024

Be a part of advancing science by participating in clinical research.
Have a question for Dr. Koren? Email him at [email protected]
Listen on Spotify
Listen on Apple Podcasts
Watch on YouTube

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.
Follow us on Social Media:
Facebook
Instagram
X (Formerly Twitter)
LinkedIn
Want to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com
Music: Storyblocks - Corporate Inspired
Thank you for listening!

Chapters

1. Patient Retention in Clinical Trials (00:00:00)

2. Sticking With Clinical Trials (00:15:54)